Feb. 18, 2021 11:57 AM ETSinovac Biotech Ltd. (SVA)By: Dulan Lokuwithana, SA News Editor4 Comments
CoronaVac,
the COVID-19 vaccine developed by Sinovac Biotech (NASDAQ:SVA) has shown efficacy against the variants first detected in the
U.K. and South Africa,
an official from Butantan biomedical center, the company’s Brazilian partner has said.
“We have tested this vaccine in China against the English and the South African variants,
with good results,” said Dimas Covas,
CEO of Butantan without offering further details.
The tests are also underway to evaluate its efficacy against the Brazilian variant, he has added.
Based on results from late-stage trials, the vaccine based on an inactivated virus has shown 100% and 83.7% efficacy against hospitalized/
severe/
fatal cases and
cases requiring medical treatment, respectively.
Now read: Vectoring Back In On Verrica Pharmaceuticals
https://seekingalpha.com/news/3663539-sinovacs-covid-19-vaccine-is-said-to-be-effective-against-new-variants?utm_source=advfn.com&utm_medium=referral
Recent SVA News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/16/2025 01:48:28 PM
- SINOVAC Issues Statement Regarding Privy Council Judgment • Business Wire • 01/16/2025 01:01:00 PM
- シノバック、手足口病(HFMD)に対する2価ワクチンの第III相臨床試験を開始 • Business Wire • 12/17/2024 01:06:00 PM
- SINOVAC hat eine klinische Phase-III-Studie zu einem bivalenten Impfstoff gegen Hand-Fuß-Mund-Krankheit (HFMD) initiiert • Business Wire • 12/17/2024 01:04:00 PM
- SINOVAC a lancé un essai clinique de Phase III sur un vaccin bivalent contre la maladie mains-pieds-bouche (MMPB) • Business Wire • 12/17/2024 01:02:00 PM
- SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD) • Business Wire • 12/16/2024 10:04:00 AM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/12/2024 08:03:46 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/16/2024 08:15:10 PM
- SINOVAC Reports Unaudited First Half of 2024 Financial Results • Business Wire • 08/16/2024 12:54:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 06/17/2024 08:02:44 PM
- SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F • Business Wire • 04/29/2024 09:53:00 PM
- Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend] • Edgar (US Regulatory) • 02/21/2024 11:09:13 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/21/2024 11:02:10 AM
- Sinovac Amends Shareholder Rights Plan • Business Wire • 02/21/2024 07:56:00 AM
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption • UMAV • Feb 6, 2025 8:30 AM
VAYK Project $700K 2024 Revenue with $150K Net Profit • VAYK • Feb 5, 2025 12:43 PM
UAV Corp (UMAV) Kicks Off Landmark "SKY" Hangar Project with Land Clearing at Costin Airport Setting Stage for Q1 2025 Groundbreaking • UMAV • Feb 5, 2025 8:30 AM
HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future • HLYK • Feb 4, 2025 8:00 AM
Wytec Wins Multi-State Government Contract for AI Gunshot Detection • WYTC • Feb 3, 2025 7:16 AM
UAV Corp. Retains Legal Counsel to Address Legacy Debt from HTTI Era; 500 Million Authorized Shares Confirmed - UAV Corp. Delivers on Strategic Commitments • UMAV • Jan 31, 2025 1:30 PM